Baxter International (BAX) Cash from Financing Activities (2009 - 2026)

Baxter International (BAX) reported Cash from Financing Activities of -$11.0 million for Q1 2026, up 99.66% year-over-year from -$5.5 million in Q1 2025, and up 92.52% quarter-over-quarter from -$147.0 million in Q4 2025.

Baxter International (BAX) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Baxter International (BAX) has 18 years of Cash from Financing Activities data on file, last reported at -$11.0 million in Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at -$11.0 million, up 99.66% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.0 billion (up 75.98% YoY), and the FY2025 annual result was -$4.2 billion, down 290.01% from the prior year.
  • Cash from Financing Activities advanced to -$11.0 million in Q1 2026 per BAX's latest filing, from -$147.0 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $141.0 million in Q4 2024 and troughed at -$3.2 billion in Q1 2025.
  • A 5-year average of -$602.1 million and a median of -$147.0 million in 2025 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities tumbled 2366.39% in 2023, then surged 104.8% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$119.0 million in 2022, then plunged by 2366.39% to -$2.9 billion in 2023, then surged by 104.8% to $141.0 million in 2024, then tumbled by 204.26% to -$147.0 million in 2025, then surged by 92.52% to -$11.0 million in 2026.
  • Business Quant data shows BAX's Cash from Financing Activities at -$11.0 million in Q1 2026, -$147.0 million in Q4 2025, and -$81.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -1.35 Bn
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -414.00 Mn
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -13.00 Mn
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn -255.24 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn -308.70 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -50.00 Mn
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -75.80 Mn
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -48.13 Mn
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -11.00 Mn
10 Aptargroup 7.72 Bn 7.52 Bn 351.91 Mn -230.34 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -11.00 Mn
Mar 31, 2026 -11.00 Mn
Dec 31, 2025 -147.00 Mn
Dec 31, 2025 -147.00 Mn
Sep 30, 2025 -81.00 Mn
Sep 30, 2025 -81.00 Mn
Jun 30, 2025 -762.00 Mn
Jun 30, 2025 -762.00 Mn
Mar 31, 2025 -3.23 Bn
Mar 31, 2025 -3.23 Bn
Dec 31, 2024 141.00 Mn
Dec 31, 2024 141.00 Mn
Sep 30, 2024 -146.00 Mn
Sep 30, 2024 -146.00 Mn
Jun 30, 2024 -936.00 Mn
Jun 30, 2024 -936.00 Mn
Mar 31, 2024 -140.00 Mn
Mar 31, 2024 -140.00 Mn
Dec 31, 2023 -2.94 Bn
Dec 31, 2023 -2.94 Bn